Michael Vasconcelles's Net Worth
-$21.2 Thousand
Who is Michael Vasconcelles?
Michael Vasconcelles does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Unum Therapeutics Inc., Magenta Therapeutics, Inc., and ImmunoGen, Inc..
SEC CIK
Michael Vasconcelles's CIK is 0001734755
Past Insider Trading and Trends
2022 was Michael Vasconcelles's most active year for acquiring shares with 2 total transactions. Michael Vasconcelles's most active month to acquire stocks was the month of November. 2024 was Michael Vasconcelles's most active year for disposing of shares, totalling 3 transactions. Michael Vasconcelles's most active month to dispose stocks was the month of January. 2023 saw Michael Vasconcelles paying a total of $21,245.27 for 1,327 shares, this is the most they've acquired in one year. In 2024 Michael Vasconcelles cashed out on 1,011,842 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Unum Therapeutics Inc. (COGT) Snapshot price: $10.47
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ImmunoGen, Inc. (IMGN) No price found
EVP R&D & MEDICAL AFFAIRS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.33K |
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 1.33K |
$16.01 | $21,245.27 | 1.33K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kura Oncology, Inc. (KURA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
No matching records found |